Prophylaxis with weekly versus daily fluconazole for fungal infections in patients with AIDS.
about
Antifungal interventions for the primary prevention of cryptococcal disease in adults with HIVIn vitro and in vivo activities of SCH 56592 (posaconazole), a new triazole antifungal agent, against Aspergillus and CandidaTreatment of cryptococcosis in the setting of HIV coinfection.HIV: primary and secondary prophylaxis for opportunistic infections.Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997.Treatment of acute cryptococcal disease.Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.2001 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus.Prevention of HIV-associated opportunistic infections and diseases in the age of highly active antiretroviral therapy.Primary prophylaxis of cryptococcal disease with fluconazole in HIV-positive Ugandan adults: a double-blind, randomised, placebo-controlled trial.New Insights into HIV/AIDS-Associated Cryptococcosis.Determinants of early and late mortality among HIV-infected individuals receiving home-based antiretroviral therapy in rural Uganda.Primary prophylaxis for cryptococcal meningitis and impact on mortality in HIV: a systematic review and meta-analysis.Oropharyngeal candidiasis in head and neck cancer patients treated with radiation: update 2011.Utility of Cryptococcal Antigen Screening and Evolution of Asymptomatic Cryptococcal Antigenemia among HIV-Infected Women Starting Antiretroviral Therapy in Thailand.A controlled trial of itraconazole as primary prophylaxis for systemic fungal infections in patients with advanced human immunodeficiency virus infection in Thailand.2001 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus.
P2860
Q24246431-EE663134-2159-4857-95D7-8A7A0F8ECE12Q28344464-058F9A37-91B6-407B-8055-2917FACCF6AAQ30366117-7E6BC55E-2610-4FA4-8D3B-E54BF91D7358Q33850498-8461E7F8-48EA-42D8-8ADB-443CD9E63820Q34085884-4A630AEF-714A-4C85-93A7-298BAF0E1A53Q34390201-53955746-B0C7-45A1-A771-5E067833FCBFQ34490092-6F6E6196-4228-4169-9ADF-AA5513A3377BQ34505582-0FC5101A-C055-43EF-9F21-CAC7741C0838Q35614631-E8B2BF40-3F6C-4F46-BCDD-BAA339C20972Q35917465-6D52383B-27A1-49E6-B4B9-20C8C408FB07Q36870447-497468A8-1548-432E-B667-58F85D4BB868Q37156556-0944962B-7473-4857-803A-775A71D09F2FQ37174438-3AAD42A6-C4A7-4D8B-B76D-9EB24BA64B27Q37407836-BB372347-D24B-4371-AB16-C31C4839414EQ37863536-11FCCD7E-AE0B-4FA9-9D3C-829FABB432D2Q42248892-2CF3C5C1-A9C3-41B7-9194-D1AC7C1DA0D2Q43820687-C9CB76D8-37A2-480F-BAC9-82D80310346AQ44616568-D067CECE-4EB4-42C2-B706-C6E38B5237D1
P2860
Prophylaxis with weekly versus daily fluconazole for fungal infections in patients with AIDS.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Prophylaxis with weekly versus ...... ections in patients with AIDS.
@en
Prophylaxis with weekly versus ...... ections in patients with AIDS.
@nl
type
label
Prophylaxis with weekly versus ...... ections in patients with AIDS.
@en
Prophylaxis with weekly versus ...... ections in patients with AIDS.
@nl
prefLabel
Prophylaxis with weekly versus ...... ections in patients with AIDS.
@en
Prophylaxis with weekly versus ...... ections in patients with AIDS.
@nl
P2093
P356
P1476
Prophylaxis with weekly versus ...... ections in patients with AIDS.
@en
P2093
Bozzette SA
Cheeseman SH
Forthal DN
MacGregor RR
McCutchan JA
P304
P356
10.1086/515018
P407
P577
1998-12-01T00:00:00Z